Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-09
DOI
10.1038/s41418-019-0343-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heat shock protein-90 toward theranostics: a breath of fresh air in idiopathic pulmonary fibrosis
- (2018) Philippe Bonniaud et al. EUROPEAN RESPIRATORY JOURNAL
- Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis
- (2017) Akiharu Kimura et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway
- (2017) Yingying Shen et al. OncoImmunology
- A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
- (2016) Antoine Daina et al. ChemMedChem
- Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
- (2016) Stéphane Champiat et al. CLINICAL CANCER RESEARCH
- HSP110T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer
- (2016) Olivier Buhard et al. JOURNAL OF MEDICAL GENETICS
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules
- (2016) Haim Ashkenazy et al. NUCLEIC ACIDS RESEARCH
- HSP110 promotes colorectal cancer growth through STAT3 activation
- (2016) K Berthenet et al. ONCOGENE
- Erratum: Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
- (2016) W Huang et al. ONCOGENE
- Erratum: The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
- (2016) A-L Joly et al. ONCOGENE
- Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer
- (2016) Akiharu Kimura et al. Oncotarget
- Extracellular HSP110 skews macrophage polarization in colorectal cancer
- (2016) Kevin Berthenet et al. OncoImmunology
- HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma
- (2015) R. Zappasodi et al. BLOOD
- HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin
- (2015) Nancy Yu et al. MOLECULAR AND CELLULAR BIOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil–Based Chemotherapy
- (2013) Ada Collura et al. GASTROENTEROLOGY
- Hsp110 Is aBona FideChaperone Using ATP to Unfold Stable Misfolded Polypeptides and Reciprocally Collaborate with Hsp70 to Solubilize Protein Aggregates
- (2013) Rayees U. H. Mattoo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype
- (2012) C. Mantel et al. BLOOD
- The heat shock proteins as targets for radiosensitization and chemosensitization in cancer
- (2012) David M. Guttmann et al. CANCER BIOLOGY & THERAPY
- Metazoan Hsp70 machines use Hsp110 to power protein disaggregation
- (2012) Heike Rampelt et al. EMBO JOURNAL
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- Structural Characterizations of Oligopyridyl Foldamers, α-Helix Mimetics
- (2011) Jana Sopkova-de Oliveira Santos et al. Journal of Chemical Information and Modeling
- Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
- (2011) Coralie Dorard et al. NATURE MEDICINE
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
- (2010) Ki Y. Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Significant overexpression of Hsp110 gene during colorectal cancer progression
- (2009) Slaby ONCOLOGY REPORTS
- Hsp110 Is a Nucleotide-activated Exchange Factor for Hsp70
- (2008) Claes Andréasson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now